Tuesday 14 October 2025
Saal 2
08.00 – 09.00 AM
Session 6
Plenary Session
Plenary Session
Chairs: Gil Yosipovitch, USA | Gary Lewin, Germany
08.00 – 08.20 AM
Inflammatory itch, a role for cytokines
Mark Hoon, USA
Mark Hoon, USA
08.20 – 08.40 AM
IgE-independent mast cell activation limits itchscratch reflex to preserve barrier integrity
Thomas Plum, Germany
Thomas Plum, Germany
08.40 – 09.00 AM
Mrgpr Channels in itch: from mouse to man
Xinzhong Dong, USA
Xinzhong Dong, USA
09.00 – 09.45 AM
Session 7
Best of German itch CRCs
Best of German itch CRCs
Chairs: Bernhard Homey, Germany | Ethan Lerner, USA
09.00 – 09.15 AM
Correlation of intra-epidermal nerve-fiber innervation depth with itch intensity in AD
Konstantin Agelopoulos, Germany
Konstantin Agelopoulos, Germany
09.15 - 09.30 AM
Integrated clinical-electrical stimulation and RNA-seq identifies a pruritus-specific gene signature in AD vs psoriasis
Peter Olah, Germany
Peter Olah, Germany
09.30 - 09.45 AM
Somatic symptom disorder: higher pruritus intensity, stress and reduced quality of life in chronic pruritus
Stefan Kahnert, Germany
Stefan Kahnert, Germany
10.30 AM - 12.00 PM
Session 8
Clinics: Role of Psychological factors
Clinics: Role of Psychological factors
Chairs: Laurent Misery, France | Jacek Szepietowski, Poland
10.30 AM - 10.50 AM
Psyche and itch: new clinical and molecular findings
Eva Peters, Germany
Eva Peters, Germany
10.50 - 11.10 AM
Patient acceptance and stigmatization in psoriasis
Adam Reich, Poland
Adam Reich, Poland
11.10 - 11.30 AM
Placebo and nocebo effects in itch
Antoinette van Laarhoven, Netherlands
Antoinette van Laarhoven, Netherlands
11.30 - 11.50 AM
Itch in different age groups: Relationship with psychological factors
Christina Schut, Germany
Christina Schut, Germany
11.50 AM - 12.00 PM
Questions & Answers
12.00 - 12.30 PM
Break
12.30 - 01.30 PM
LUNCH SYMPOSIUM
REDEFINING TREATMENT OUTCOMES IN PRURIGO NODULARIS: DERMATOLOGIST AND PATIENT PERSPECTIVES
REDEFINING TREATMENT OUTCOMES IN PRURIGO NODULARIS: DERMATOLOGIST AND PATIENT PERSPECTIVES
Prof. Dr. med. Elke Weishaar, Heidelberg
Prof. Dr. med. Dr. h.c. Sonja Ständer, Münster
Prof. Dr. med. Dr. h.c. Sonja Ständer, Münster
01.30 - 01.45 PM
Break
01.45 - 02.45 PM
Session 9
Round table Itch and pain encoding
Round table Itch and pain encoding
Moderators:
Martin Schmelz, Germany | Earl Carstens, USA
Discussants
Ethan Lerner, USA | Matthias Ringkamp, USA | Laurent Misery, France
Martin Schmelz, Germany | Earl Carstens, USA
Discussants
Ethan Lerner, USA | Matthias Ringkamp, USA | Laurent Misery, France
01.45 - 02.05 PM
Specificity vs. pattern specificity of experimental models
02.05 - 02.25 PM
Terminology of chronic itch and pain
02.25 - 02.45 PM
Translation of itch encoding from experimental approaches to the clinics
02.45 - 03.45 PM
Session 10
Clinics
Clinics
Chairs: Christina Schut, Germany | Adam Reich, Poland
02.45 - 03.05 PM
Chronic pruritus in older adults:
Epidemiology, associated factors, and impact on quality of life
Juliette Bollemeijer, Netherlands
Epidemiology, associated factors, and impact on quality of life
Juliette Bollemeijer, Netherlands
03.05 - 03.25 PM
Itch in malignancy
Jacek Szepietowski, Poland
Jacek Szepietowski, Poland
03.25 - 03.45 PM
Hematological itch
Madeline Caduc, Germany
Madeline Caduc, Germany
03.45 - 04.15 PM
Break
04.00 - 05.15 PM
Session 11
Chairs: Sonja Ständer, Germany | Elke Weisshaar, Germany
04.15 - 04.35 PM
Future perspectives in basic research of itch
Martin Schmelz, Germany
Martin Schmelz, Germany
04.35 - 04.55 PM
Future perspectives in treatment of itch
Martin Schmelz, Germany
Martin Schmelz, Germany
04.55 - 05.15 PM
Scratching the surface no more: 20 years of IFSI advancing itch research and treatment
Gil Yosipovitch, USA
Gil Yosipovitch, USA
05.15 - 05.30 PM
Prizes & Closing Ceremony
Forum
09.00 – 09.45 AM
Session 7
Clinics: Best of clinical trials
Clinics: Best of clinical trials
Chairs: Alan Fleischer, USA | Franz Legat, Austria
09.00 – 09.15 AM
Pooled REMIX-1/-2 phase 3 data:
Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria
Martin Metz, Germany
Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria
Martin Metz, Germany
09.15 – 09.30 AM
Nemolizumab long-term safety and efficacy up to 104 weeks in the ARCADIA open-label extension study in adolescents and adults with moderate-to-severe atopic dermatitis
Matthias Augustin, Germany
Matthias Augustin, Germany
09.30 – 09.45 AM
Lebrikizumab provides skin clearance and itch relief at week 16 and week 52: pooled results from 2 phase 3 studies ADvocate1 and ADvocate2
Martin Metz, Germany
Martin Metz, Germany
09.45 – 10.30 AM
Break
10.30 – 12.00 PM
Session 8
Research: Itch mechanisms in inflammatory skin diseases
Research: Itch mechanisms in inflammatory skin diseases
Chairs: Mark Hoon, USA | Manuel Pereira, Germany
10.30 – 10.50 AM
Kappa opioids inhibit spinal circuits to suppress itch
Tayler Sheahan, Germany
Tayler Sheahan, Germany
10.50 – 11.10 AM
Novel findings on IL 31
Bernhard Homey, Germany
Bernhard Homey, Germany
11.10 – 11.30 AM
Parabrachial to central amygdala:
central itch neurons
Darya Pavlenko, USA
central itch neurons
Darya Pavlenko, USA
11.30 – 11.50 AM
Itch mechanism in aged skin
Mitsutoshi Tominaga, Japan
Mitsutoshi Tominaga, Japan
11.50 AM – 12.00 PM
Questions & Answers
12.00 - 12.30 PM
Break
12.30 - 01.30 PM
LUNCH SYMPOSIUM
Itch in chronic spontaneous urticaria
Itch in chronic spontaneous urticaria
PD Dr. med. Manuel Pereira, Berlin
Prof. Dr. med. Martin Metz, Berlin
Prof. Dr. med. Martin Metz, Berlin
02.45 - 03.45 PM
Session 10
Clinics
Clinics
Chairs: Simon Müller, Switzerland | Christelle Le Gall-Ianotto, France
02.45 - 03.05 PM
The many faces of itch in India
Asit Mittal, India
Asit Mittal, India
03.05 - 03.25 PM
Itching in Africa
Grace Mulyowa, Uganda
Grace Mulyowa, Uganda
03.25 - 03.45 PM
Itching in keloids and scars
Hong Liang Tey, Singapore
Hong Liang Tey, Singapore